Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes ... - Endocrine Today PDF Print
Endocrine TodayDarbepoetin alfa did not decrease the risk for death, cardiovascular or renal events in patients with type 2 diabetes, chronic kidney disease and moderate

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.